PubMed:32338224 / 6935-7063 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T219","span":{"begin":71,"end":79},"obj":"CHEBI:6541"},{"id":"T220","span":{"begin":71,"end":79},"obj":"CHEBI:6541"},{"id":"T221","span":{"begin":109,"end":117},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"In this framework, Gurwitz [40] proposed to use AT1R blockers, such as losartan, as a potential treatment of COVID-19 infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T42","span":{"begin":109,"end":117},"obj":"Disease"},{"id":"T43","span":{"begin":118,"end":127},"obj":"Disease"}],"attributes":[{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"In this framework, Gurwitz [40] proposed to use AT1R blockers, such as losartan, as a potential treatment of COVID-19 infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T101","span":{"begin":84,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"In this framework, Gurwitz [40] proposed to use AT1R blockers, such as losartan, as a potential treatment of COVID-19 infection."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40","span":{"begin":71,"end":79},"obj":"Chemical"}],"attributes":[{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_6541"}],"text":"In this framework, Gurwitz [40] proposed to use AT1R blockers, such as losartan, as a potential treatment of COVID-19 infection."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T42","span":{"begin":0,"end":128},"obj":"DRI_Background"}],"text":"In this framework, Gurwitz [40] proposed to use AT1R blockers, such as losartan, as a potential treatment of COVID-19 infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T42","span":{"begin":0,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In this framework, Gurwitz [40] proposed to use AT1R blockers, such as losartan, as a potential treatment of COVID-19 infection."}